Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Non Operating Income (2020 - 2025)

Historic Non Operating Income for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $1.4 million.

  • Cytek Biosciences' Non Operating Income fell 6769.58% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year increase of 3905.41%. This contributed to the annual value of $14.8 million for FY2024, which is 2214.07% up from last year.
  • Per Cytek Biosciences' latest filing, its Non Operating Income stood at $1.4 million for Q3 2025, which was down 6769.58% from $3.8 million recorded in Q2 2025.
  • Over the past 5 years, Cytek Biosciences' Non Operating Income peaked at $7.3 million during Q4 2024, and registered a low of -$980000.0 during Q1 2021.
  • Over the past 5 years, Cytek Biosciences' median Non Operating Income value was $1.7 million (recorded in 2024), while the average stood at $1.9 million.
  • Per our database at Business Quant, Cytek Biosciences' Non Operating Income tumbled by 54193.55% in 2021 and then soared by 59647.06% in 2023.
  • Over the past 5 years, Cytek Biosciences' Non Operating Income (Quarter) stood at -$873000.0 in 2021, then skyrocketed by 573.88% to $4.1 million in 2022, then rose by 2.68% to $4.2 million in 2023, then skyrocketed by 72.72% to $7.3 million in 2024, then crashed by 80.61% to $1.4 million in 2025.
  • Its Non Operating Income was $1.4 million in Q3 2025, compared to $3.8 million in Q2 2025 and $3.7 million in Q1 2025.